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OBJECTIVES In this study we attempt to define the clinical and echocardiographic characteristics of
patients with left atrial spontaneous echo contrast (LASEC) in sinus rhythm (NSR).
BACKGROUND Left atrial spontaneous echo contrast in atrial fibrillation (AF) is associated with increased risk
of thromboembolism. Little is known about its significance in NSR.
METHODS We reviewed reports of 1,288 transesophageal echocardiogram (TEE) studies done with a
5 MHz probe. Patients with swirling LASEC who were in NSR during TEE were analyzed.
We compared them with a control group of 45 age matched patients selected to have NSR,
left atrium (LA) .4.0 cm but no SEC.
RESULTS Spontaneous echo contrast in NSR was noted in 24 patients (2%) and formed our study
group. All patients with SEC had enlarged LA, mean 5.6 cm 6 0.6 cm. There was a higher
prevalence of cerebrovascular accident (CVA) in patients with SEC when compared with
controls with no SEC, 83% versus 56%, p 5 0.02. Patients with SEC had larger LA, 5.6
versus 4.9 cm, p , 0.0001 and lower mean peak left atrial appendage emptying velocity
(LAAEV), 38 versus 56 cm/s, p 5 0.001. Thirteen percent of patients with SEC had LA
thrombus as compared with none in the control group, p 5 0.02. By multivariate analysis,
SEC in NSR was found to be associated with CVA, larger LA size and decreased mean
LAAEV. Even after adjusting for LA size, patients with SEC had a higher prevalence of
CVA than controls, p 5 0.03.
CONCLUSIONS Spontaneous echo contrast in NSR occurs in patients with significantly dilated LA and
depressed atrial function. Left atrial thrombus is noted in 13% of such patients despite NSR.
Spontaneous echo contrast in NSR is associated with a higher prevalence of CVA. Further,
SEC is found to be an independent and more powerful correlate of CVA than reduced
LAAEV or atrial size. These data indicate that LASEC in NSR is a prothombotic condition.
(J Am Coll Cardiol 2000;35:1932–8) © 2000 by the American College of Cardiology
Spontaneous echocardiographic contrast (SEC) or “smoke”
in the left atrium (LA) is a pattern of increased blood
echogenicity caused by ultrasonic backscatter from red
blood cell aggregates. These aggregates form due to non-
covalent binding between red cells and plasma proteins
under low flow and low shear conditions (1–3). Since this
interaction is largely independent of platelet and coagulation
cascade, it is unaltered by the administration of antiplatelet
and anticoagulant drugs (2,3). Even though stasis of blood
in the LA is the most significant factor contributing to
SEC, clinical studies have demonstrated correlation with
hemorheological abnormalities such as increased hematocrit
and increased fibrinogen levels (3,4).
Several studies have shown that SEC is a frequent finding
in patients with atrial fibrillation (AF), mitral stenosis and
in patients with prior thromboembolism, occurring in about
30% to 60% of such patients, depending on clinical circum-
stances (5–15). The clinical importance of SEC in such
patients is its association with LA thrombus and increased
thromboembolic complications. Most of these studies, how-
ever, involved patients with AF; there is very little data on
the significance of SEC in sinus rhythm (NSR). The
purpose of our study was to define the clinical and echocar-
diographic characteristics of patients with left atrial spon-
taneous echo contrast (LASEC) in NSR and to evaluate its
clinical significance in relation to LA thrombus and cardiac
embolism.
METHODS
Study group selection and characteristics. We analyzed
the reports of 1,288 consecutive transesophageal echocar-
diograms (TEE) performed between the years 1993 through
1997. All TEE were performed using Omniplane 5 MHz
From the Division of Cardiology, St. Luke’s-Roosevelt Hospital Center, Columbia
University, College of Physicians and Surgeons, New York, New York. This study
was supported, in part, by a grant from Mr. Munio Podhorzer. This study was
presented, in part, at the 71st Scientific Sessions of the American Heart Association,
November 1998, Dallas, Texas.
Manuscript received July 30, 1999; revised manuscript received December 16,
1999, accepted February 21, 2000.
Journal of the American College of Cardiology Vol. 35, No. 7, 2000
© 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)00643-4
probes on Hewlett Packard Sonos 1000 echocardiographs,
according to recognized guidelines (16). Echocardiograms
with SEC were selected and reviewed. Patients with swirl-
ing SEC in the LA who were in NSR during TEE were
chosen for analysis. Patients in AF or flutter at the time of
TEE were excluded from this study. Left atrial SEC was
diagnosed by the presence of swirling dynamic smoke-like
echoes within the atrial cavity that was distinct from white
noise artifact. The presence and severity of SEC were
determined independently by two different echocardio-
graphers, and any discrepancy was resolved by consensus.
Spontaneous echo contrast was graded as 0 5 no smoke, 11
5 mild smoke visible in some portion of the LA, 21 5
dense smoke that appeared throughout the LA. The pres-
ence of LA thrombus, diagnosed as a clearly defined
echo-dense intracavitary mass not due to the pectinate
muscles of the LA appendage (LAA), was specifically
sought. Peak LAA emptying velocity (LAAEV) was mea-
sured using pulsed Doppler with the sample volume placed
1 cm inside the orifice of LAA. Visualization of the thoracic
aorta was routinely performed, and any protruding athero-
mas $4 mm were noted.
A two-dimensional and Doppler transthoracic echocar-
diogram performed before TEE was analyzed in all patients.
Standard acoustic windows had been obtained using a
2.5 MHz transducer. On the apical four-chamber view, the
LA size was measured in two dimensions, length (antero-
posterior dimension) and width (lateral dimension). Ven-
tricular function and ejection fraction were visually evalu-
ated and qualitatively assessed as normal, mild, moderate or
severe dysfunction. The presence or absence of left ventric-
ular (LV) hypertrophy was determined, and mitral inflow
velocities E, A and E:A ratio were measured. Since we
hypothesized that diastolic dysfunction might predispose to
LA stasis, mitral inflow velocities were used to evaluate LV
diastolic dysfunction and were categorized as impaired
relaxation, pseudonormalization or restrictive patterns (17).
Standard criteria were used to quantify mitral regurgitation
as mild, moderate or severe (18).
Clinical characteristics of study patients were obtained
from patient records. The clinical data collected included
age, gender and traditional cardiovascular risk factors—
hypertension, diabetes mellitus, smoking and hypercholes-
terolemia. We noted the presence of clinical coronary artery
disease, congestive heart failure (CHF), significant valve
abnormalities including prosthetic valves, past history of
paroxysmal AF or flutter, stroke or transient ischemic
attack, peripheral emboli and carotid stenosis. In all patients
the clinical indication necessitating the performance of
TEE was also noted.
Control group. In order to better define the significance
of smoke in NSR and its relation to thromboembolism, a
control group of 45 patients with no SEC were randomly
selected from the initial 600 consecutive TEE studies.
Controls were age matched to the case group, had no
SEC, were in NSR, had LA dilation .4.0 cm on
M-mode and no significant mitral regurgitation. These
characteristics were chosen to attempt to match baseline
characteristics of the two groups, except for the presence
of SEC. We chose patients with no significant mitral
regurgitation (MR) because the presence of significant
MR reduces the occurrence of SEC in the LA (19). We
chose patients with large LA for the control group to
attempt to exclude the influence of LA size, to isolate the
effect of SEC. In a fashion similar to the case group,
clinical information, transthoracic and TEE variables
were obtained.
After obtaining data from both the case and control
groups, the results were sequentially analyzed in the follow-
ing steps. First, we defined the characteristics of patients
with SEC in NSR. Next, we compared the case group with
a control group of patients with no SEC. Since patients
with SEC had other factors that can be associated with
cerebrovascular accident (CVA), such as increased LA size
(20) and decreased LAAEV, we decided to further analyze
our data by combining both the case and control groups
together. Then we compared patients with CVA and no
CVA to determine the factors that were independently
associated with CVA.
Statistics. Statistical analyses were performed using SPSS
version 6.1 (SPSS Inc., Chicago, Illinois). Variables are
presented as mean 6 SEM. Student t test was used to test
the difference in the means of variables between patients
with and without SEC who had TEE. Mantel-Haenszel
chi-square was calculated to test whether the indicator
variables were independent of each other. A forward step-
wise method was used to select four significant variables
with p # 0.05 for entry into a multivariate regression
analysis. Similar analyses were then performed to evaluate
the differences between patients with and without CVA.
Then, a multivariate logistic regression analysis (with step-
wise method) was performed on this combined group using
all echocardiographic variables with p # 0.25. The relation-
ship between SEC and CVA was also tested by a logistic
regression analysis with LA size as a covariate. In all
Abbreviations and Acronyms
AF 5 atrial fibrillation
CHF 5 congestive heart failure
CVA 5 cerebrovascular accident
LA 5 left atrium or atrial
LAA 5 left atrial appendage
LAAEV 5 left atrial appendage emptying velocity
LASEC 5 left atrial spontaneous echo contrast
LV 5 left ventricle or ventricular
MR 5 mitral regurgitation
NSR 5 sinus rhythm
SEC 5 spontaneous echo contrast
TEE 5 transesophageal echocardiogram
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analyses, a two-tailed p value of #0.05 was considered
significant.
RESULTS
Of 1,288 consecutive TEE studies performed, 195 patients
(15%) had swirling SEC in the LA. Of these, 24 patients
(12%) were in sinus rhythm and formed our study group.
This represented 2% of our overall TEE population.
Among the 1,288 TEE studies, 50% were referred for TEE
to detect a source of CVA.
Clinical characteristics of patients with LASEC in NSR.
The clinical and echocardiographic characteristics of the
patients with LASEC are depicted in Tables 1 and 2,
respectively. The mean age was 72 years. There was a high
prevalence of manifest cardiac disease. Coronary artery
disease was present in 58%, CHF in 33%, valve stenosis in
12% (two mitral stenosis and one aortic stenosis), prosthetic
valves in 21% (two prosthetic aortic valves, one prosthetic
mitral valve and two patients with both) and a past history
of AF or flutter in 25%. Hypertension was present in 71%.
Past history of CVA was noted in 83%.
Echocardiographic characteristics of patients with
LASEC in NSR. Spontaneous echo contrast was 21 in
83% of the study group. All patients with SEC had
significantly dilated LA. The mean LA size was 5.6 6
0.6 cm. The mean LAAEV was reduced, 38 cm/s (median
35); 58% had a decreased emptying velocity, #40 cm/s. Left
atrial thrombus was noted in 13%. Sixty-seven percent of
patients had normal LV systolic function, while 25% had
severe and 8% had mild to moderate LV dysfunction. Left
ventricular thrombus was noted in 4%. Forty-one percent of
patients had LV hypertrophy. Mitral inflow velocities con-
sistent with diastolic dysfunction were noted in 33% of
patients; 12% had a restrictive pattern and 21% had im-
paired relaxation or pseudonormalization. No patient with
SEC had moderate or severe MR. Severe atherosclerosis of
the aorta with protruding atheromas $4 mm was noted in
38% of patients. Conditions that could predispose to stasis
of blood within the LA such as reduced LAAEV, mitral
stenosis, systolic or diastolic LV dysfunction and a past
history of AF or flutter were present in 92% of patients.
However, two patients (8%) had LA dilatation as their sole
abnormality with none of the above mentioned factors.
Comparison of patients with LASEC in NSR and con-
trol group with no SEC. Our control group was selected
to have no SEC, NSR, dilated LA .4.0 cm and no
significant MR. We selected such a control population to try
to isolate SEC as a single variable. Control patients also had
a high prevalence of manifest cardiac disease. Comparison
of the two groups (Tables 1 and 2) revealed no significant
differences in the prevalence of cardiovascular risk factors,
coronary artery disease, CHF, prosthetic valves, history of
Table 1. Comparison of Clinical Characteristics of Patients





(n 5 45) p Value
Age (yrs) 72 6 10 70 6 11 0.50
Men % 58 38 0.10
HTN % 71 80 0.39
DM % 17 38 0.07
CAD % 58 49 0.46
H/o A-fib/flutter % 25 27 0.88
Mitral stenosis % 8 0 0.10
Prosthetic valve % 21 11 0.27
Endocarditis % 8 4 0.50
CVA % 83 56 0.02*
Carotid stenosis % 13 16 0.70
CHF % 33 31 0.85
VVI pacemaker % 4 2 0.64
CAD 5 coronary artery disease; CHF 5 congestive heart failure; CVA 5 cerebro-
vascular accident; DM 5 diabetes mellitus; H/o A-fib/flutter 5 history of atrial
fibrillation or atrial flutter; HTN 5 hypertension; SEC 5 spontaneous echo contrast;
VVI 5 ventricular paced and ventricular sensed.
*p , 0.05.





(n 5 45) p Value
LA size length (cm) 5.6 6 0.6 4.9 6 0.5 ,0.0001*
LA size width (cm) 4.5 6 0.7 4.1 6 0.4 0.02*
LV systolic dysfunction % 33 24 0.43
LV ejection fraction 0.48 6 0.16 0.53 6 0.11 0.15
LVH % 46 49 0.81
LV Diastolic dysfunction % 33 53 0.11
Mean LAAEV (cm/s) 38 6 19 56 6 17 0.001*
LAAEV ,40 cm/s % 58 5 0.001*
LA thrombus % 13 0 0.02*
LV thrombus % 4 2 0.64
Severe aortic atheromas % 38 33 0.73
LA 5 left atrium; LAAEV 5 left atrial appendage emptying velocity; LV 5 left ventricle; LVH 5 left ventricular hypertrophy;
SEC 5 spontaneous echo contrast.
*p , 0.05.
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AF or LV dysfunction. A high prevalence of CVA was
noted in both the groups. This reflects the referral bias intrinsic
to TEE studies. Despite this referral bias, a higher prevalence
of CVA was noted in patients with SEC as compared with the
control group, 83% versus 56%, p 5 0.02. Patients with SEC
had a larger LA, 5.6 versus 4.9 cm, p , 0.0001. Patients with
SEC had a lower mean LAAEV, 38 versus 56 cm/s, p 5
0.001. Fifty-eight percent of patients with SEC had
LAAEV ,40 cm/s compared with only 5% of controls.
Importantly, 13% of patients with SEC had LA thrombus as
compared with none in the control group, p 5 0.02.
By multivariate analysis, CVA, larger LA size and de-
creased mean LAAEV were significantly associated with
SEC in NSR (Table 3). Even after adjusting for LA size,
patients with SEC had higher prevalence of stroke than
controls, p 5 0.03.
Comparison of patients with CVA and no CVA in the
combined group. Patients with SEC have other factors
that can be associated with CVA, such as increased LA size
and decreased LAAEV. Therefore, the data was further
analyzed by combining case and control groups together to
compare patients with CVA and no CVA to determine
which factors correlate independently with stroke. Tables 4
and 5 present these data.
Spontaneous echo contrast in LA was more prevalent in
patients with stroke as compared with patients with no
stroke, 44% versus 17%, p 5 0.02. Among all the clinical
and echocardiographic variables, only SEC was significantly
associated with CVA. Patient age and other risk factors
were similar between both groups. History of AF and LV
function was comparable. Though more patients with CVA
had protruding atheromas, 40% versus 25%, this difference
did not reach statistical significance. The mean LA size (5.0
vs. 5.1 cm) as well as the mean LAAEV (48 vs. 54 cm/s) was
not significantly different between the two groups. By the
multivariate analysis, including SEC, LAAEV, ejection
fraction, LA thrombus and protruding aortic atheromas,
SEC was the only independent correlate of CVA, p 5 0.026.
DISCUSSION
Most prior studies of LASEC have been of patients with
AF or mitral stenosis. The prevalence of SEC varies
depending on the patient population studied. In AF, SEC
occurs in 45% to 60% of patients. In AF patients, SEC is
related to large LA dimension and decreased atrial mechan-
ical function and is associated with increased risk of LA
thrombus and embolic complications. Stroke or embolic
event rate is 12% per year in AF patients with SEC,
compared with 3% per year in AF patients with no SEC.
Left atrial thrombus occurs in 12% to 24% of AF patients
with SEC (5,13,14).
In patients with mitral stenosis regardless of rhythm,
SEC is noted in 65% to 80% of cases. Again, the presence
of SEC is particularly associated with large LA size and
increased risk of thromboembolism. Left atrial thrombus is
detected in 18% to 23% of patients with mitral stenosis
(6,7,9,15). In patients with acute CVA or chronic cerebro-
vascular disease, SEC occurs in 32% to 38% and is associ-
ated with increased risk of LA thrombus (8,10). These data
effectively establish the prothrombotic nature of SEC and
its strong association with clinical thromboembolism.
Prevalence of LASEC in NSR. In this study, LASEC was
found in 15% of all patients undergoing TEE. In the group
with SEC, 12% had smoke during NSR. Thus, the preva-
lence of SEC in NSR among our patients who were referred
for TEE is about 2%. These findings are very similar to the
results of Black, who described an SEC prevalence of 19%
among 400 consecutive patients undergoing TEE. Similar
to our findings, 13% of patients with SEC in their study
were in NSR, 2.5% of their entire group (13). However, in
that study, 6 of 10 patients with SEC in NSR were found
to have mitral stenosis, while our larger study had a much
lower prevalence of mitral stenosis (8%). A previous study of
SEC in NSR included only patients with mitral stenosis;
SEC was noted in 45% of patients (9).
Clinical and echocardiographic characteristics of
LASEC in NSR. Our study for the first time describes the
clinical and echocardiographic correlates of LASEC in NSR
in a large patient population referred for TEE. Patients with





CVA 5 cerebrovascular accident; LA 5 left atrium; LAAEV 5 left atrial appendage
emptying velocity; NSR 5 sinus rhythm; SEC 5 spontaneous echo contrast.
*p , 0.05.
Table 4. Comparison of Clinical Characteristics of Patients




(n 5 24) p Value
Age (yrs) 71 6 11 69 6 12 0.36
Men % 49 37 0.36
HTN % 80 71 0.39
DM % 29 33 0.70
CAD % 53 50 0.79
H/o A-fib/flutter % 22 33 0.32
Mitral stenosis % 2 4 0.60
Pros valve % 11 21 0.27
Endocarditis % 2 13 0.08
Carotid stenosis % 18 8 0.29
CHF % 27 42 0.21
VVI pacemaker % 4 0 0.29
CAD 5 coronary artery disease; CHF 5 congestive heart failure; CVA 5 cerebro-
vascular accident; DM 5 diabetes mellitus; H/o A-fib/flutter 5 history of atrial
fibrillation or atrial flutter; HTN 5 hypertension; VVI 5 ventricular paced and
ventricular sensed.
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LASEC had a large prevalence of clinically manifest heart
disease—coronary artery disease, CHF, paroxysmal AF and
valve stenosis. But, when we compared the SEC group to
age matched controls, we found that the only independent
predictors of SEC were prior CVA, large LA size and
decreased mean LAAEV (Tables 1 and 2). Left atrial size in
patients with SEC was even larger than the control group
preselected for LA size .4.0 cm. Though we had hypoth-
esized a priori that history of paroxysmal AF, presence of
severe LV dysfunction, LV hypertrophy and LV diastolic
dysfunction might correlate with SEC, these variables were
no different between the case and control groups.
We did find a decrease in mean peak LAAEV in the
LASEC group indicating impaired atrial appendage me-
chanical function. More patients with SEC in NSR had
decreased LAAEV, suggesting that a depressed atrial con-
tractile function is a causative factor in the development of
SEC in NSR. In light of the high prevalence of manifest
cardiac disease, fixed atrial contractile dysfunction may be
the largest contributor to decreased LAAEV; however, we
cannot exclude that the SEC group had more undetected
AF and LA stunning (21). Consistent with the prior
observations that turbulent flow originating from significant
MR may protect against the formation of SEC, no patients
in the LASEC group had significant MR (19).
An important observation in our study was that 13% of
patients with SEC had LA thrombus despite NSR. No
patient in the control group had LA thrombus. This
prevalence of thrombus is similar to the 12% to 24%
prevalence noted in patients with AF and SEC (4,5,14).
Further, a higher prevalence of CVA was noted in our study
patients compared with control patients without SEC.
Moreover, when cases with SEC were combined together
with controls, SEC was the only independent predictor of
CVA. These observations indicate that SEC represents a
prothrombotic state even in patients with NSR and that the
high prevalence of LA thrombus may be responsible for the
higher stroke rates.
SEC vs. LAAEV. Our results indicate that LASEC is a
more powerful correlate of stroke than depressed LAAEV.
Comparison of patients with CVA and no CVA revealed no
difference in mean LAAEV (48 cm/s vs. 54 cm/s); only
prevalence of SEC was significantly different (44% vs. 17%)
p 5 0.02. Recently, attention has focused on the association
between depressed LAAEV, LA thrombus and stroke.
Tabata et al. (22) showed that patients in NSR with high
pulmonary venous wedge pressure had significantly de-
creased LAAEV and larger LAA area. Among the 11
patients in NSR with high wedge pressure, one had LA
thrombus and two had SEC. These observations suggest
that, even in patients with NSR, a marked elevation of LA
pressure can reduce LAAEV and predispose to thrombus
formation. Kamalesh et al. (23) reported two patients with
embolic stroke in NSR and depressed LAAEV. Impor-
tantly, both patients had SEC and LA thrombus. LAA
function in stroke patients with NSR was depressed com-
pared with control patients with NSR with no stroke and
was similar to the depressed LAA function in patients with
chronic AF. Thus, the triad of SEC, depressed LAAEV
and LA thrombus has been previously reported in patients
with NSR and stroke. Our data suggest that though
depressed LAAEV is a cause for SEC, it is the latter that
correlates more highly with CVA.
Fibrinogen and SEC. Several clinical and epidemiological
studies have shown an association between increased fibrin-
ogen levels and stroke and cardiovascular mortality (24–26).
Besides other mechanisms, increased fibrinogen levels pre-
dispose to the formation of LASEC; positively charged
fibrinogen acts as a bridge between negatively charged red
cells, facilitating aggregation (1–3). An underlying condi-
tion that may lead to stasis of blood in the LA was noted in




(n 5 24) p Value
LA size length (cm) 5.2 6 0.6 5.1 6 0.7 0.38
LA size width (cm) 4.3 6 0.5 4.2 6 0.6 0.71
LV systolic dysfunction % 31 21 0.37
LV ejection fraction 0.50 6 0.14 0.55 6 0.10 0.13
LVH % 47 50 0.79
LV diastolic dysfunction % 49 42 0.57
SEC % 44 17 0.02*
Mean LAAEV (cm/s) 48 6 20 54 6 18 0.22
LAAEV ,40 cm/s % 29 11 0.10
LA thrombus % 7 0 0.19
LV thrombus % 4 0 0.29
Severe aortic atheromas % 40 25 0.22
CVA 5 cerebrovascular accident; LA 5 left atrium; LAAEV 5 left atrial appendage emptying velocity; LV 5 left ventricle;
LVH 5 left ventricular hypertrophy; SEC 5 spontaneous echo contrast.
*p , 0.05.
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92% of our patients with SEC. However, two patients with
SEC (8%) in NSR had dilated LA as the sole abnormality.
In AF patients with SEC, higher fibrinogen levels are found
(4). We advance the untested hypothesis that higher fibrin-
ogen levels may be found in SEC patients in NSR as well.
This might explain SEC in the absence of any abnormality
but LA dilation. These two patients did not have depressed
LAAEV, so undetected AF is not a likely cause.
Study limitations. Study design: our study was an obser-
vational retrospective study of a selected group of patients
from a referred TEE population. However, our results on
the overall prevalence of LASEC is similar to that obtained
in several other studies involving a wide variety of patients.
Further, the prevalence of SEC in NSR is similar to the
prevalence obtained by analysis of a previous smaller study
(13). Control patients, though they have LA dilation, were
not matched for the magnitude of LA dilation found in the
SEC group. Though control group patients had LA dilation
.4.0 cm, there were few patients, even in this large clinical
experience, with the high degree of LA dilation found in the
SEC group, who were also in NSR, with no significant MR
and no SEC. Most patients with this large LA size and no
SEC were in AF or had significant MR. Even after
adjusting for LA size by covariate analysis, patients with
SEC had a higher prevalence of stroke than controls. Since
SEC in NSR is uncommon, the number of study patients
was relatively small, and, hence, the results should be
interpreted with caution. The small sample size may explain
the lack of association between CVA and aortic plaques.
Prospective follow-up of patients was not performed.
Limitations pertaining to the cause of LASEC: ambula-
tory electrocardiogram monitoring of patients with LASEC
in NSR was not done but would be of interest to ascertain
whether undetected paroxysmal AF is a cause. Systematic
analysis of diastolic function of the LV was not performed;
diastolic dysfunction was assessed with mitral inflow veloc-
ities and not pulmonary vein velocities in all patients.
Hence, we cannot exclude that our patients had a higher
prevalence of diastolic dysfunction than the 33% noted in
our study population. We did not measure serum levels of
fibrinogen or other plasma proteins to correlate with SEC in
NSR. Future studies addressing this limitation would be of
interest.
Conclusions. The data in this study indicate that LASEC
in NSR is a distinct clinical phenomenon occurring in 2% of
the referred TEE population. It occurs in patients with
significantly dilated LA. Its association with decreased
LAAEV indicates that depressed atrial contractile function
is also a causative factor.
Left atrial thrombus occurs in a significant proportion of
patients with LASEC despite NSR. We hypothesize that a
combination of increased LA size and decreased LA me-
chanical function from whatever cause predispose to SEC
and thrombus formation. We have found an association
between SEC in NSR and a higher prevalence of CVA.
Further, SEC is found to be an independent and more
powerful correlate of CVA than reduced LAAEV. The data
in this study indicate that LASEC in NSR is a prothrom-
botic condition. A natural history study to prospectively
follow such patients would be of interest.
A higher prevalence of LA thrombus and stroke even in
NSR raises another question: whether patients with SEC in
NSR would benefit from anticoagulation. Spontaneous echo
contrast in a given patient provides additional objective
evidence of significantly depressed atrial mechanical func-
tion, LA stasis and a prothrombotic milieu that might
warrant anticoagulation therapy. A possible treatment ben-
efit from anticoagulation in such patients warrants study as
well.
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